Content
NHMRC's Performance Measurement Framework 2003-2006
In September 2004 Council approved the 2003-06
Performance Measurement Framework (PMF) that aligns with
the seven outcomes of the 2003-06 Strategic Plan.
The revised PMF links the Strategic Plan and the NHMRC's legislative objectives to an outcome-output framework that is the Department of Finance and Administration's preferred model for performance measurement. This framework emphasises what the NHMRC produces (outputs) and what impacts or consequences (outcomes) this has for the community.
NHMRC Outcome - Output Framework 2003 - 06
Health outcome 9: Knowledge, information and training for developing better strategies to imrove the health of Australians.
![]()
NHMRC outcome 9.1: Health research, ethics, advice and regulation.
![]()
-
Outcome 1: Creating new knowledge
-
Outcome 2: Enhancing capacity to innovate
-
Outcome 3: Utilising knowledge
-
Outcome 4: Ensuring high ethical standards
-
Outcome 5: Strengthening communications and collaborations
-
Outcome 6: Regulating embryo research and maintaining the prohibition of human cloning
-
Outcome 7: Achieving high standards of governance and accountability
The PMF is an update of the original that was built on the conceptual research outcomes framework agreed to by Government following the 1999 Health and Medical Research Strategic Review. In 2002, the PMF was expanded by Council to include indicators of performance in the health advisory and health ethics roles
Using the Performance Measurement Framework
The PMF is a management tool that is integral to the NHMRC's planning and reporting processes and has three main purposes to:
- assist and inform the NHMRC's internal business processes, including the development of business plans and the NHMRC's Strategic Plan;
- demonstrate a return on investment in health and medical research funding; and
- utilise a range of reporting strategies informing both the Australian Government and the Australian community on NHMRC's performance in meeting its strategic objectives and legislative requirements.
The indicators and measures have been chosen on the basis that they are appropriate, achievable (albeit some more immediately than others) and proportionate to the scale of the activity, and have been developed to:
- include a balance of inputs, processes, outputs and outcomes;
- highlight the synergies between research, health advice, health ethics and embryo research regulation;
- provide a baseline for comparing data over time; and
- address existing gaps that currently inhibit our ability to fully demonstrate the impacts that NHMRC funded activities provide
Outcome 1 - Creating new knowledge
Indicator 1.1: Increased investment leading to high impact research |
Targets |
|---|---|
|
80% of MREA allocated to research activities |
|
Increased demand for NHMRC support |
|
New Indicator - data to be benchmarked through a peer review process and reported in 2005 |
| Indicator 1.2: Growth in internationally competitive knowledge | Targets |
|---|---|
|
Above national average |
|
New Indicator - to be benchmarked against selected OECD and regional countries |
[top]
Outcome 2 - Enhancing capacity to innovate
| Indicator 2.1: Expanded and mobile research workforce | Targets |
|---|---|
|
20% of MREA allocated to people support activities |
|
Increased demand for NHMRC support |
|
Increase in total workforce and new new workforce |
|
New indicator - (data to be benchmarked and reported) |
|
7 Howard Florey fellowships in 2005 |
|
90% of training awards and scholarships completed within time |
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
| Indicator 2.2: Increased international recognition of Australian researchers | Targets |
|---|---|
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
| Indicator 2.3: Growth in access to and availability of facilities and equipment | Targets |
|---|---|
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
[top]
Outcome 3 - Utilising knowledge
| Indicator 3.1: Increased uptake of NHMRC health advice and information | Targets |
|---|---|
|
New indicator - Ratings to be identified for each stakeholder group through a benchmarking survey |
|
New indicator - data to be benchmarked and reported |
| Indicator 3.2: Improved transfer of knowledge into health policy and practice | Targets |
|---|---|
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
|
75% of new products address issues in a national priority area |
| Indicator 3.3: Increased commercial activity | Targets |
|
2.5% of MREA budget allocated to commercialising discovery |
|
Increased demand for NHMRC support |
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
[top]
Outcome 4 - Ensuring high ethical standards
| Indicator 4.1: Improved support, advice and guidance on ethics issues in health and for conducting research | Targets |
|---|---|
|
|
|
2 new |
|
National conference May 2005 |
|
4 AHEC bulletins/year |
|
HRECs 90% aware, 80% satisfied |
| Indicator 4.2: Compliance with NHMRC ethics guidelines | Targets |
|---|---|
|
100% compliance |
|
100% compliance |
[top]
Outcome 5 - Strengthening communications and collaborations
| Indicator 5.1: Growth in collaborations and partnerships | Targets |
|---|---|
|
5% of new funding awarded per annum matched by external funding |
|
40% of research involves national
collaboration |
| Indicator 5.2: Increased engagement with the community | Targets |
|---|---|
|
NHMRC consultation processes are receiving increased positive responses from the public and stakeholders as appropriate |
|
New Indicator - data to be benchmarked and reported. |
|
5% increase above current combined sales/download levels |
|
80% of stakeholders aware of NHMRC
support |
|
New indicator - data to be benchmarked and reported |
|
Enhanced awareness of specific issues |
[top]
Outcome 6 - Regulating embryo research and maintaining the prohibition of human cloning
| Indicator 6.1: An effective national system of regulation | Targets |
|---|---|
|
Six monthly report to Parliament on licences |
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
|
New indicator - data to be benchmarked and reported |
| Indicator 6.2: Compliance with the legislation | Targets |
|---|---|
|
New indicator - data to be benchmarked and reported |
|
Unqualified audits |
|
Report to both Houses of Parliament and COAG by 19 December 2005 |
[top]
Outcome 7 - Achieving high standards of governance and accountability
| Indicator 7.1: Effective planning, monitoring and reporting | Targets |
|---|---|
|
Council report to Minister on implementation by end of 2005 (Strategic Plan approved by Minister at beginning of triennium) |
|
Management Committee report every six months to Council on unacceptable risks |
|
Submission of the NHMRC Annual Report,
Strategic Plan, Department of Health and Ageing
Annual Report |
|
Expenditure to be within allocated budget |
| Indicator 7.2: Effective information management | Targets |
|---|---|
|
All records are complete and accessible |
|
100% recorded and supported by evidence |
|
90% of users satisfied |
| Indicator 7.3: Effective governance arrangements | Targets |
|---|---|
|
Review effectiveness of governance by October 2005 |
|
90% of stakeholders satisfied |
|
Triennial multi-source appraisal of Executive and Chairs completed by October 2005 |
[top]
